Suppr超能文献

医院获得性血流感染与临床脓毒症

Nosocomial bloodstream infection and clinical sepsis.

作者信息

Hugonnet Stéphane, Sax Hugo, Eggimann Philippe, Chevrolet Jean-Claude, Pittet Didier

机构信息

Infection Control Program, University of Geneva Hospitals, Geneva, Switzerland.

出版信息

Emerg Infect Dis. 2004 Jan;10(1):76-81. doi: 10.3201/eid1001.030407.

Abstract

Primary bloodstream infection (BSI) is a leading, preventable infectious complication in critically ill patients and has a negative impact on patients' outcome. Surveillance definitions for primary BSI distinguish those that are microbiologically documented from those that are not. The latter is known as clinical sepsis, but information on its epidemiologic importance is limited. We analyzed prospective on-site surveillance data of nosocomial infections in a medical intensive care unit. Of the 113 episodes of primary BSI, 33 (29%) were microbiologically documented. The overall BSI infection rate was 19.8 episodes per 1,000 central-line days (confidence interval [CI] 95%, 16.1 to 23.6); the rate fell to 5.8 (CI 3.8 to 7.8) when only microbiologically documented episodes were considered. Exposure to vascular devices was similar in patients with clinical sepsis and patients with microbiologically documented BSI. We conclude that laboratory-based surveillance alone will underestimate the incidence of primary BSI and thus jeopardize benchmarking.

摘要

原发性血流感染(BSI)是重症患者中一种主要的、可预防的感染性并发症,对患者的预后有负面影响。原发性BSI的监测定义区分了微生物学确诊的感染和未确诊的感染。后者被称为临床脓毒症,但其流行病学重要性的相关信息有限。我们分析了某医疗重症监护病房医院感染的前瞻性现场监测数据。在113例原发性BSI病例中,33例(29%)为微生物学确诊。原发性BSI的总体感染率为每1000个中心静脉导管日19.8例(95%置信区间[CI],16.1至23.6);仅考虑微生物学确诊病例时,感染率降至5.8例(CI 3.8至7.8)。临床脓毒症患者和微生物学确诊的BSI患者接触血管装置的情况相似。我们得出结论,仅基于实验室的监测会低估原发性BSI的发病率,从而损害基准指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f0d/3322756/1979a7a0767d/03-0407-F.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验